Indeed, mutations of Nav1.2 have been associated with autism (Sanders et al., 2012; Ben-Shalom et al., 2017) and epilepsy (Kamiya et al., 2004; Lauxmann et al., 2013; Berecki et al., 2018). Here, SCN2A is linked to epilepsy.